Ex Parte BIERMANN et al - Page 16




          Appeal No. 2001-0611                                                        
          Application No. 08/742,733                                                  


          bone.  Based on these reference teachings, we are in agreement              
          with the examiner’s position to the effect that it would have               
          been obvious to one of ordinary skill in the art to make the                
          implant of Goble of thermoplastic material having an elastic                
          modulus like that of bone, and to partially embed in the surface            
          thereof a biocompatible material, in order to derive the benefits           
          taught by Moumene and Bokros.  Thus, we conclude that the                   
          reference evidence applied by the examiner is sufficient to                 
          establish a prima facie case of obviousness of claim 19/11.                 
               The only argument that reasonably appears to be directed               
          against claims 18-20 is found on page 7 of the main brief,                  
          wherein appellants argue that claim 18                                      
               recites unobvious subject matter for the reasons                       
               recited above in Applicants’ response to [the]                         
               Examiner’s rejection of claims 11-17.  For the reasons                 
               discussed above in conjunction with claims 11, 26-28,                  
               43 and 44, claims 19-23 are not rendered obvious by                    
               Goble et al., in view of Moumene et al. and Bokros et                  
               al.                                                                    
               Appellants’ very general argument in favor of patentability            
          is simply not persuasive that the examiner erred in rejecting               
          claim 19/11.  Accordingly, we shall sustain the rejection of                
          representative claim 19/11, as well as claims 18, 19/43, 19/44,             
          20 that we have grouped with claim 19/11.                                   


                                         16                                           





Page:  Previous  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  Next 

Last modified: November 3, 2007